Abstract:OBJECTIVE:To analyze the germline variations of genes RET, VHL, SDHD and SDHB in patients with pheochromocytoma and/or paraganglioma and to evaluate variations of these genes in Chinese patients.METHODS:Patients who were treated in Peking University First Hospital from September 2012 to March 2014 and diagnosed with pheochromocytoma and/or paraganglioma by pathologists were included in this study. Twelve patients were included in total, of whom 11 had pheochromocytoma, and 1 had paraganglioma. Deoxyribonucleic acid (DNA) was extracted from the leukocytes of peripheral blood of the patients. The exons 10, 11, 13-16 of the RET gene, and all exons of VHL, SDHB and SDHD genes and their nearby introns (±20 bp) were amplified with polymerase chain reactions, and the products were sent to a biotechnology company for sequencing. The sequencing results were compared with wildtype sequences of these genes to identify variations. One of the patients was diagnosed with multiple endocrine neoplasia type 2A. A family analysis was performed in his kindred, and his family members received genetic tests for the related variations.RESULTS:Three patients were found to have germline gene variations. A c.136C>T (p.R46X) variation of the SDHB gene was found in a patient with malignant pheochromocytoma. A c.1901G>A (C634Y) variation, as well as c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene were found in a patient with multiple endocrine neoplasia type 2A. After a family analysis, five family members of this patient were found to have the same variations. c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene were also found in a clinical sporadic patient without evidence of malignancy. A patient with congenital single ventricle malformation and pheochromocytoma was included in this study, and no variation with clinical significance was found in the four genes of this patient.CONCLUSION:25% (3/12) patients with pheochromocytoma or paraganglioma were found to have missense or nonsense germline gene variations in this study, including the c.136C>T (p.R46X) variation of the SDHB gene, the c.1901G>A (C634Y) variation of the RET gene, and c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene. The former two variations have already been confirmed to be pathogenic. The existence of these variations in Chinese patients with pheochromocytoma and/or paraganglioma was validated in this study, which supports the conclusion that genetic testing is necessary to be generally performed in patients with pheochromocytoma and/or paraganglioma.

[Mutation screening of RET proto-oncogene in Chinese sporadic patients with pheochromocytoma].

Screening of RET Gene Mutations in Chinese Patients with Medullary Thyroid Carcinoma and Their Relatives

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

Germline RECQL Gene Mutations in Chinese Patients with Breast Cancer

[Germline Gene Testing of the RET, VHL, SDHD and SDHB Genes in Patients with Pheochromocytoma/paraganglioma].

Detection of the Mutation of RET Proto-Oncogene in a Pedigree with Multiple Endocrine Neoplasia 2 A

[Clinical Diagnosis and Treatment of Familial Medullary Thyroid Carcinoma Caused by a P.c618y RET Proto-Oncogene Mutation in a Chinese Pedigree].

RET c.1901G>A and Novel SLC12A3 Mutations in Familial Pheochromocytomas

[A Case Report and Pedigree Study of a Single Point Mutation in RET Proto-Oncogene and Type 2B Multiple Endocrine Neoplasia].

[The Clinical Patterns and RET Proto-Oncogene Identification of Pheochromocytoma in 13 Multiple Endocrine Neoplasia Type 2A Pedigrees].

The Rare Intracellular RET Mutation P.s891a in a Chinese Han Family with Familial Medullary Thyroid Carcinoma

Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma

Mutation of the ret proto-oncogene in two Chinese families with multiple endocrine neoplasia type 2A(MEN2A).

Polymerase Chain Reaction-Single Strand Conformational Polymorphism Analysis of Rearranged During Transfection Proto-Oncogene in Chinese Familial Hirschsprung's Disease.

[Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].

Genetic screening in pheochromocytoma and paraganglioma

Multiple Endocrine Neoplasia Type 2A Caused by a P.c618r RET Proto-Oncogene Mutation in a Chinese Pedigree

Screening of RET Gene Mutation in a Large Chinese Pedigree with Multiple Endocrine Neoplasia Type 2A

Investigation of RET Proto-Oncogene Mutation in Patients with Medullary Thyroid Carcinoma

RET Proto-Oncogene Genetic Screening of Families with Multiple Endocrine Neoplasia Type 2 Optimizes Diagnostic and Clinical Management in China.

Mutation of RET Gene in Chinese Patients with Hirschsprung’s Disease